Pt Medikaloka Hermina Tbk Reports Earnings Results for the Nine Months Ended September 30, 2020
November 11, 2020 at 10:47 am IST
Share
PT Medikaloka Hermina Tbk announced earnings results for the nine months ended September 30, 2020. For the nine months, the company announced sales was IDR 2,882,809 million compared to IDR 2,687,719 million a year ago. Operating income was IDR 549,849 million compared to IDR 454,550 million a year ago. Net income was IDR 261,655 million compared to IDR 210,052 million a year ago. Basic earnings per share was IDR 88.16 compared to IDR 70.65 a year ago. Diluted earnings per share was IDR 86.85. Diluted earnings per share from continuing operations was IDR 86.85.
PT Medikaloka Hermina Tbk is an Indonesia-based company, which is engaged in offering general hospital services. The Company is focused on providing services for BPJS patients to support government program in Indonesia. The Companyâs services include hospitals, specialties, and featured services. The Companyâs hospitals include Hermina Arcamanik, Hermina Balikpapan, Hermina Banyumanik, Hermina Bekasi, Hermina Bitung, Hermina Bogor, Hermina Ciledug, Hermina Cilegon and Hermina Ciputat. In specialties service, the Company provides anatomical pathology, andrology, anesthesiology, cardiology, clinical microbiology, clinical pathology, dentistry, dermatology and venereology, dietetics, emergency medicine, forensic and medicolegal, internal medicine, medical acupuncture, neurology, and surgery. Its subsidiaries include PT Medikaloka Internusa (M Internusa), PT Medikaloka Sejahtera (M Sejahtera), PT Medikaloka Husada (M Husada), PT Medikaloka Daan Mogot and PT Medikaloka Pasteur (M Pasteur).